{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:08:31Z","timestamp":1722816511241},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T00:00:00Z","timestamp":1455321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10689-016-9878-4","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T14:29:55Z","timestamp":1455373795000},"page":"371-384","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["M\u00fcllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery"],"prefix":"10.1007","volume":"15","author":[{"given":"Murray Joseph","family":"Casey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes B.","family":"Colanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,13]]},"reference":[{"key":"9878_CR1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","volume":"117","author":"HT Lynch","year":"1966","unstructured":"Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (1966) Hereditary factors in cancer: study of two large Midwestern kindreds. Arch Intern Med 117:206\u2013212","journal-title":"Arch Intern Med"},{"key":"9878_CR2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0016-5085(19)34179-4","volume":"53","author":"HT Lynch","year":"1967","unstructured":"Lynch HT, Krush AJ (1967) Heredity and adenocarcinoma of the colon. Gastroenterology 53:517\u2013527","journal-title":"Gastroenterology"},{"key":"9878_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02586773","volume":"22","author":"HT Lynch","year":"1979","unstructured":"Lynch HT, Lynch PM (1979) The cancer-family syndrome: a pragmatic basis for syndrome identification. Dis Colon Rectum 22:106\u2013110","journal-title":"Dis Colon Rectum"},{"key":"9878_CR4","first-page":"801","volume":"36","author":"HT Lynch","year":"1999","unstructured":"Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801\u2013818","journal-title":"J Med Genet"},{"key":"9878_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","volume":"81","author":"M Aarnio","year":"1999","unstructured":"Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltom\u00e4ki P, Mecklin J-P, J\u00e4rvinen H-J (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214\u2013218","journal-title":"Int J Cancer"},{"key":"9878_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1011590617833","volume":"1","author":"P Watson","year":"2001","unstructured":"Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 1:57\u201360","journal-title":"Fam Cancer"},{"key":"9878_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10689-007-9165-5","volume":"7","author":"HT Lynch","year":"2008","unstructured":"Lynch HT, Lynch JF, Lynch PM, Attard T (2008) Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 7:27\u201339","journal-title":"Fam Cancer"},{"key":"9878_CR8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23508","volume":"123","author":"P Watson","year":"2008","unstructured":"Watson P, Vasen HFA, Mecklin J-P, Bernstein I, Aarnio M, J\u00e4rvinen HJ, Myrh\u00f8j T, Sunde L, Wijnen JT, Lynch HT (2008) The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444\u2013449","journal-title":"Int J Cancer"},{"key":"9878_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAP.0b013e3181bb6bdc","volume":"16","author":"AM Bellizzi","year":"2009","unstructured":"Bellizzi AM, Frankel WL (2009) Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 16:405\u2013417","journal-title":"Adv Anat Pathol"},{"key":"9878_CR10","first-page":"644","volume":"133","author":"HT Lynch","year":"1971","unstructured":"Lynch HT, Krush AJ (1971) Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet 133:644\u2013648","journal-title":"Surg Gynecol Obstet"},{"key":"9878_CR11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.1972.03210130023005","volume":"222","author":"HT Lynch","year":"1972","unstructured":"Lynch HT, Krush AJ, Lemon HM, Kaplan AR, Condit PT, Bottomley RH (1972) Tumor variation in families with breast cancer. JAMA 222:1631\u20131635","journal-title":"JAMA"},{"key":"9878_CR12","first-page":"717","volume":"138","author":"HT Lynch","year":"1974","unstructured":"Lynch HT, Guirgis HA, Albert S, Brennan M, Lynch J, Kraft C, Pocekay D, Vaughns C, Kaplan A (1974) Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 138:717\u2013724","journal-title":"Surg Gynecol Obstet"},{"key":"9878_CR13","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(197804)41:4<1543::AID-CNCR2820410444>3.0.CO;2-Y","volume":"41","author":"HT Lynch","year":"1978","unstructured":"Lynch HT, Harris RE, Guirgis HA, Maloney K, Carmody MK, Lynch JF (1978) Familial association of breast\/ovarian carcinoma. Cancer 41:1543\u20131548","journal-title":"Cancer"},{"key":"9878_CR14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/1097-0142(19910301)67:5<1460::AID-CNCR2820670534>3.0.CO;2-S","volume":"67","author":"HT Lynch","year":"1991","unstructured":"Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, Lynch JF, Ponder BAJ (1991) Hereditary ovarian cancer. Heterogeneity in age at diagnosis. Cancer 67:1460\u20131466","journal-title":"Cancer"},{"key":"9878_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-4608(91)90094-B","volume":"53","author":"HT Lynch","year":"1991","unstructured":"Lynch HT, Conway T, Lynch J (1991) Hereditary ovarian cancer. pedigree studies, Part II. Cancer Genet Cytogenet 53:161\u2013183","journal-title":"Cancer Genet Cytogenet"},{"key":"9878_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cncr.2820710213","volume":"71","author":"HT Lynch","year":"1993","unstructured":"Lynch HT, Watson P, Lynch JF, Conway TA, Fili M (1993) Hereditary ovarian cancer. Heterogeneity in age at onset. Cancer 71:573\u2013581","journal-title":"Cancer"},{"key":"9878_CR17","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"HJ Hall","year":"1990","unstructured":"Hall HJ, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset breast cancer to chromosome 17q21. Science 250:1684\u20131689","journal-title":"Science"},{"key":"9878_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0140-6736(91)90076-2","volume":"338","author":"SA Narod","year":"1991","unstructured":"Narod SA, Feunteum J, Lynch HT, Watson P, Conway T, Lenoir GM (1991) Familial breast-ovarian cancer locus on chromosome 17q12\u2013q23. Lancet 338:82\u201383","journal-title":"Lancet"},{"key":"9878_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"9878_CR20","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313. Science 265:2088\u20132090","journal-title":"Science"},{"key":"9878_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"9878_CR22","doi-asserted-by":"crossref","unstructured":"National Center for Biotechnology Information. National Institutes of Health. www.ncbi.nlm.nih.gov\/sites\/entrez?db=gene . Accessed 1 Sept 2015","DOI":"10.1002\/9783527678679.dg08217"},{"key":"9878_CR23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"9878_CR24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333","journal-title":"J Clin Oncol"},{"key":"9878_CR25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","volume":"2","author":"JK Tobacman","year":"1982","unstructured":"Tobacman JK, Tucker MA, Kase R, Greene MH, Costa J, Fraumeni JF Jr (1982) Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet 2:795\u2013797","journal-title":"Lancet"},{"key":"9878_CR26","first-page":"93S","volume":"66","author":"KT Chen","year":"1985","unstructured":"Chen KT, Schooley JL, Flam MS (1985) Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gynecol 66:93S\u201394S","journal-title":"Obstet Gynecol"},{"key":"9878_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0306-9877(86)90007-1","volume":"21","author":"HT Lynch","year":"1986","unstructured":"Lynch HT, Bewtra C, Lynch JF (1986) Familial peritoneal ovarian carcinomatosis: a new clinical entity? Med Hypotheses 21:171\u2013177","journal-title":"Med Hypotheses"},{"key":"9878_CR28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2005.01.039","volume":"97","author":"MJ Casey","year":"2005","unstructured":"Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT (2005) Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Gynecol Oncol 97:457\u2013467","journal-title":"Gynecol Oncol"},{"key":"9878_CR29","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","volume":"10","author":"SR Lakhani","year":"2004","unstructured":"Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, Sobol H, Jacquemier J, Lyonet DS, Neuhausen SL, Weber B, Wagner T, Winqvist R, Bignon YJ, Monti F, Schmitt F, Lenoir G, Seitz S, Hamman U, Pharoah P, Lane G, Ponder B, Bishop DT, Easton DF (2004) Pathology of ovarian cancers in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 10:2473\u20132481","journal-title":"Clin Cancer Res"},{"key":"9878_CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.1507","volume":"202","author":"C Wang","year":"2004","unstructured":"Wang C, Horiuchi A, Imai T, Ohira S, Itoh K, Nikaido T, Katsuyama Y, Konishi I (2004) Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. J Pathol 202:215\u2013223","journal-title":"J Pathol"},{"key":"9878_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10689-004-9554-y","volume":"3","author":"MJ Casey","year":"2004","unstructured":"Casey MJ, Bewtra C (2004) Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer 3:265\u2013281","journal-title":"Fam Cancer"},{"key":"9878_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih I-M, Kurman RJ (2009) Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16:267\u2013282","journal-title":"Adv Anat Pathol"},{"key":"9878_CR33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/92.13.1088","volume":"92","author":"BA Werness","year":"2000","unstructured":"Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BAJ, Piver MS (2000) Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. J Natl Cancer Inst 92:1088\u20131091","journal-title":"J Natl Cancer Inst"},{"key":"9878_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00000478-198104000-00004","volume":"5","author":"A Foyle","year":"1981","unstructured":"Foyle A, Al-Jabi M, McCaughey WTE (1981) Papillary peritoneal tumors in women. Am J Surg Pathol 5:241\u2013249","journal-title":"Am J Surg Pathol"},{"key":"9878_CR35","unstructured":"Schoenwolf GC, Bleyl SB, Brauer PR, Francis-West PH (2015) Development of the reproductive system. In: Schoenwolf GC (ed), Larsen\u2019s human embryology, 5th edn. Philadelphia, Elsevier\/Churchill-Livingston. https:\/\/www.clinicalkey.com\/#!\/content\/book\/3-s2.0-B9781455706846000163 . Accessed September 12, 2015"},{"key":"9878_CR36","doi-asserted-by":"publisher","unstructured":"Healy A (2012) Embryology of the female reproductive tract. In: Mann GS, Blair JC, Garden AS (eds) Imaging of gynecological disorders in infants and children. Springer, Berlin, pp 21\u201330. doi: 10.1007\/174_2010_128 . Accessed 10 Sept 2015","DOI":"10.1007\/174_2010_128"},{"key":"9878_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1025700807451","volume":"2","author":"JMJ Piek","year":"2003","unstructured":"Piek JMJ, Torrenga B, Hermsen B, Verheijen RHM, Zweemer RP, Gille JJP, Kenemans P, van Diest PJ, Menko FH (2003) Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study. Fam Cancer 2:73\u201378","journal-title":"Fam Cancer"},{"key":"9878_CR38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10689-013-9651-x","volume":"12","author":"MJ Casey","year":"2013","unstructured":"Casey MJ, Bewtra C, Lynch HT, Snyder C, Stacy M, Watson P (2013) Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry. Fam Cancer 12:719\u2013740","journal-title":"Fam Cancer"},{"key":"9878_CR39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(197508)36:2<364::AID-CNCR2820360211>3.0.CO;2-C","volume":"36","author":"JF Fraumeni Jr","year":"1975","unstructured":"Fraumeni JF Jr, Grundy GW, Creagan ET, Everson RB (1975) Six families prone to ovarian cancer. Cancer 36:364\u2013369","journal-title":"Cancer"},{"key":"9878_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","volume":"76","author":"RP Zweemer","year":"2000","unstructured":"Zweemer RP, van Diest PJ, Verheijen RHM, Ryan A, Gulle JJP, Sijmons RH, Jacobs IJ, Menko FH, Kenemans P (2000) Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol 76:45\u201350","journal-title":"Gynecol Oncol"},{"key":"9878_CR41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/gyno.2000.5740","volume":"77","author":"PG Rose","year":"2000","unstructured":"Rose PG, Shrigley R, Wiesner GL (2000) Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report. Gynecol Oncol 77:319\u2013320","journal-title":"Gynecol Oncol"},{"key":"9878_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","volume":"80","author":"PJ Paley","year":"2001","unstructured":"Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA (2001) Occult cancer of the fallopian tube in BRCA-1 mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 80:176\u2013180","journal-title":"Gynecol Oncol"},{"key":"9878_CR43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","volume":"87","author":"K Leeper","year":"2002","unstructured":"Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P (2002) Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 87:52\u201356","journal-title":"Gynecol Oncol"},{"key":"9878_CR44","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260\u20131268","journal-title":"J Clin Oncol"},{"key":"9878_CR45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","volume":"26","author":"SN Agoff","year":"2002","unstructured":"Agoff SN, Mendelin JE, Grieco VS, Garcia RL (2002) Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up. Am J Surg Pathol 26:171\u2013178","journal-title":"Am J Surg Pathol"},{"key":"9878_CR46","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF, the Breast Cancer Linkage Consortium (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"9878_CR47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","volume":"90","author":"JMJ Piek","year":"2003","unstructured":"Piek JMJ, Verheijen RHM, Kenemans P, Massuger LF, Bulten H, van Diest PJ (2003) BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol 90:491","journal-title":"Gynecol Oncol"},{"key":"9878_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","volume":"13","author":"Y Lee","year":"2006","unstructured":"Lee Y, Medeiros F, Kindelberger D, Callahan MJ, Muto M, Crum CP (2006) Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol 13:1\u20137","journal-title":"Adv Anat Pathol"},{"key":"9878_CR49","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","volume":"118","author":"R Manchanda","year":"2011","unstructured":"Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG 118:814\u2013824","journal-title":"BJOG"},{"key":"9878_CR50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/1940-6207.CAPR-10-0266","volume":"4","author":"MS Yates","year":"2011","unstructured":"Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KH (2011) Microscopic and early-stage ovarian cancers in BRCA1\/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer Prev Res 4:463\u2013470","journal-title":"Cancer Prev Res"},{"key":"9878_CR51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","volume":"49","author":"W Reitsma","year":"2013","unstructured":"Reitsma W, de Bock GH, Ossterwijk JC, Bart J, Hollema H, Mourits MJE (2013) Support of the \u2018fallopian tube hypothesis\u2019 in a prospective series of risk-reducing salpingo-oophorectomy specimens. Eur J Cancer 49:132\u2013141","journal-title":"Eur J Cancer"},{"key":"9878_CR52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","volume":"129","author":"CB Powell","year":"2013","unstructured":"Powell CB, Swisher EM, Cass I, McLennan J, Norquist B, Garcia RL, Lester J, Karlan BY, Chen L (2013) Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol 129:364\u2013371","journal-title":"Gynecol Oncol"},{"key":"9878_CR53","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","volume":"32","author":"ME Sherman","year":"2014","unstructured":"Sherman ME, Piedmonte M, Mai PL, Ioffe OB, Ronnett BM, Van Le L, Ivanov I, Bell MC, Blank SV, DiSilvestro P, Hamilton CA, Tewari KS, Wakeley K, Kauff ND, Yamada SD, Rodriguez G, Skates SJ, Alberts DS, Walker JL, Minasian L, Lu K, Greene MH (2014) Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol 32:3275\u20133283","journal-title":"J Clin Oncol"},{"key":"9878_CR54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","volume":"132","author":"JR Conner","year":"2014","unstructured":"Conner JR, Meserve E, Pizer E, Garber J, Roh M, Urban N, Drescher C, Quade BJ, Muto M, Howitt BE, Pearlman MD, Berkowitz RS, Horowitz N, Crum CP, Feltmate C (2014) Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol 132:280\u2013286","journal-title":"Gynecol Oncol"},{"key":"9878_CR55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Le Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:161\u2013169","journal-title":"Am J Surg Pathol"},{"key":"9878_CR56","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","volume":"26","author":"JW Carlson","year":"2008","unstructured":"Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D, Crum CP (2008) Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 26:4160\u20134165","journal-title":"J Clin Oncol"},{"key":"9878_CR57","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","volume":"226","author":"E Kuhn","year":"2012","unstructured":"Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang T-L, Shih l-M (2012) TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions. J Pathol 226:421\u2013426","journal-title":"J Pathol"},{"key":"9878_CR58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","volume":"9","author":"NN Nik","year":"2014","unstructured":"Nik NN, Vang R, Shih I-M, Kurman RJ (2014) Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu Rev Pathol Mech Dis 9:27\u201345","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"9878_CR59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ygyno.2014.07.084","volume":"134","author":"I Cass","year":"2014","unstructured":"Cass I, Walts AE, Barbuto D, Lester J, Karlan B (2014) A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. Gynecol Oncol 134:492\u2013497","journal-title":"Gynecol Oncol"},{"key":"9878_CR60","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","volume":"120","author":"JD Seidman","year":"2011","unstructured":"Seidman JD, Zhao P, Yemelyanova A (2011) \u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol 120:470\u2013473","journal-title":"Gynecol Oncol"},{"key":"9878_CR61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2010.05.011","volume":"118","author":"D Vicus","year":"2010","unstructured":"Vicus D, Finch A, Cass I, Rosen B, Murphy J, Fan I, Royer R, McLaughlin J, Karlan B, Narod SA (2010) Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube. Gynecol Oncol 118:299\u2013302","journal-title":"Gynecol Oncol"},{"key":"9878_CR62","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1999.5568","volume":"75","author":"G Hornreich","year":"1999","unstructured":"Hornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E (1999) Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature. Gynecol Oncol 75:300\u2013304","journal-title":"Gynecol Oncol"},{"key":"9878_CR63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","volume":"92","author":"O Lavie","year":"2004","unstructured":"Lavie O, Hornreich G, Ben-Arie A, Rennert G, Cohen Y, Keidar R, Sagi S, Lahad EL, Auslander R, Beller U (2004) BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol 92:521\u2013524","journal-title":"Gynecol Oncol"},{"key":"9878_CR64","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2005.06.009","volume":"99","author":"O Lavie","year":"2005","unstructured":"Lavie O, Ben-Arie A, Pilip A, Rennert G, Cohen Y, Feiner B, Auslnader R (2005) BRCA2 germline mutation in a woman with uterine serous papillary carcinoma\u2014case report. Gynecol Oncol 99:486\u2013488","journal-title":"Gynecol Oncol"},{"key":"9878_CR65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","volume":"79","author":"R Goshen","year":"2000","unstructured":"Goshen R, Chu W, Elit L, Pal T, Hakimi J, Ackerman I, Fyles A, Mitchell M, Narod SA (2000) Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 79:477\u2013481","journal-title":"Gynecol Oncol"},{"key":"9878_CR66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","volume":"80","author":"DA Levine","year":"2001","unstructured":"Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J (2001) Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 80:395\u2013398","journal-title":"Gynecol Oncol"},{"key":"9878_CR67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2010.08.027","volume":"119","author":"F Barak","year":"2010","unstructured":"Barak F, Milgrom R, Laitman Y, Gemer O, Rabinovich A, Piura B, Anteby E, Baruch GB, Korach J, Friedman E (2010) The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients. Gynecol Oncol 119:511\u2013515","journal-title":"Gynecol Oncol"},{"key":"9878_CR68","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/IGC.0b013e3181ef622d","volume":"20","author":"I Bruchim","year":"2010","unstructured":"Bruchim I, Amichay K, Kidron D, Attias Z, Biron-Shental T, Drucker L, Friedman E, Werner H, Fishman A (2010) BRCA1\/2 germline mutation in Jewish patients with uterine serous carcinoma. Int J Gynecol Cancer 20:1148\u20131153","journal-title":"Int J Gynecol Cancer"},{"key":"9878_CR69","first-page":"1531","volume":"20","author":"O Lavie","year":"2010","unstructured":"Lavie O, Ben-Arie A, Segev Y, Faro J, Barak F, Haya N, Auslender R, Gemer O (2010) BRCA germline mutations in women with uterine serous carcinoma\u2014still a debate. Int J Gynecol Cancer 20:1531\u20131534","journal-title":"Int J Gynecol Cancer"},{"key":"9878_CR70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","volume":"119","author":"KP Pennington","year":"2013","unstructured":"Pennington KP, Walsh T, Lee M, Pennil C, Novetsky AP, Agnew KJ, Thronton A, Garcia R, Mutch D, King M-C, Goodfellow P, Swisher EM (2013) BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 119:332\u2013338","journal-title":"Cancer"},{"key":"9878_CR71","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/IGC.0000000000000402","volume":"25","author":"MJ Casey","year":"2015","unstructured":"Casey MJ, Bewtra C, Lynch HT, Snyder CL, Stacey M (2015) Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications. Int J Gynecol Cancer 25:650\u2013656","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 1","key":"9878_CR72","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","volume":"95","author":"WT Creasman","year":"2006","unstructured":"Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz APM, Ngan HYS, Pecorelli S (2006) Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S105\u2013S143","journal-title":"Int J Gynaecol Obstet"},{"key":"9878_CR73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2013.02.023","volume":"129","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moor RG, Downs LS, Soslow RA, Zaino R (2013) Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 129:277\u2013284","journal-title":"Gynecol Oncol"},{"key":"9878_CR74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2012.09.012","volume":"127","author":"MG Carmen del","year":"2012","unstructured":"del Carmen MG, Birrer M, Schorge JO (2012) Uterine papillary serous cancer: a review of the literature. Gynecol Oncol 127:651\u2013661","journal-title":"Gynecol Oncol"},{"key":"9878_CR75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PGP.0b013e318273fc55","volume":"32","author":"A Semaan","year":"2013","unstructured":"Semaan A, Mert I, Munkarah AR, Bandyopadhyay S, Mahdi HS, Winer IS, Nucci MR, Hussein Y, Quershi F, Hayek K, Tabassum F, Alosh B, Schultz DS, Cote ML, Vijver KK, Morris RT, Oliva E, Ali-Fehmi R (2013) Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study. Int J Gynecol Pathol 32:181\u2013187","journal-title":"Int J Gynecol Pathol"},{"issue":"9 suppl 3","key":"9878_CR76","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/IGC.0000000000000264","volume":"24","author":"S Sagae","year":"2014","unstructured":"Sagae S, Susumu N, Viswanathan AN, Aoki D, Backes FJ, Provencher DM, Vaughan M, Creutzberg CL, Kurzeder C, Kristensen G, Lee C, Kurtz J-E, Glasspool RM, Small W Jr (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma. Int J Gynecol Cancer 24(9 suppl 3):S83\u2013S89","journal-title":"Int J Gynecol Cancer"},{"key":"9878_CR77","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.20645","volume":"101","author":"DM Boruta II","year":"2004","unstructured":"Boruta DM II, Gehrig PA, Groben PA, Bae-Jump V, Boggess JF, Fowler WC Jr, Van Le L (2004) Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference? Cancer 101:2214\u20132221","journal-title":"Cancer"},{"key":"9878_CR78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2004.12.045","volume":"96","author":"W Zheng","year":"2005","unstructured":"Zheng W, Schwartz PE (2005) Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol 96:579\u2013582","journal-title":"Gynecol Oncol"},{"key":"9878_CR79","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","volume":"28","author":"EA Jarboe","year":"2009","unstructured":"Jarboe EA, Miron A, Carlson JW, Hirsch MS, Kindelberger D, Mutter GL, Crum CP, Nucci MR (2009) Coexisting intraepithelial serous carcinoma of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol 28:308\u2013315","journal-title":"Int J Gynecol Pathol"},{"key":"9878_CR80","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.mehy.2009.11.029","volume":"74","author":"L Massuger","year":"2010","unstructured":"Massuger L, Roelofsen T, van Ham M, Bulten J (2010) The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis. Med Hypothesis 74:859\u2013861","journal-title":"Med Hypothesis"},{"key":"9878_CR81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/IGC.0b013e3182434a81","volume":"22","author":"T Roelofsen","year":"2012","unstructured":"Roelofsen T, van Kempen LCLT, van der Laak JAWM, van Ham MA, Bulten J, Massuger LFAG (2012) Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion? Int J Gynecol Cancer 22:457\u2013464","journal-title":"Int J Gynecol Cancer"},{"key":"9878_CR82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0000000000000109","volume":"34","author":"MC Tolcher","year":"2015","unstructured":"Tolcher MC, Swisher EM, Medeiros F, Lima JF, Hilderbrand JL, Donovan JL, Garcia RL, Cliby WA, Dowdy SC (2015) Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma. Int J Gyencol Pathol 34:57\u201364","journal-title":"Int J Gyencol Pathol"},{"key":"9878_CR83","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAT.0b013e328360b6e7","volume":"45","author":"CJR Stewart","year":"2013","unstructured":"Stewart CJR, Doherty DA, Havlat M, Koay MHE, Leung YC, Naran A, O\u2019Brien D, Ruba S, Salfinger S, Tan J (2013) Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis. Pathology 45:382\u2013387","journal-title":"Pathology"},{"key":"9878_CR84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/modpathol.2014.76","volume":"28","author":"L Jia","year":"2015","unstructured":"Jia L, Yuan Z, Wang Y, Cragun JM, Kong B, Zheng W (2015) Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma. Mod Pathol 28:118\u2013127","journal-title":"Mod Pathol"},{"key":"9878_CR85","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/modpathol.2013.212","volume":"27","author":"MJJM Mingles","year":"2014","unstructured":"Mingles MJJM, van Ham MAPC, de Kievit IM, Snijders MPML, van Tilborg AAG, Bulten J, Massuger LFAG (2014) M\u00fcllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol. Mod Pathol 27:1002\u20131013","journal-title":"Mod Pathol"},{"key":"9878_CR86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00000478-199801000-00015","volume":"22","author":"C Zhou","year":"1998","unstructured":"Zhou C, Gilks CB, Hayes M, Clement PB (1998) Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 22:113\u2013120","journal-title":"Am J Surg Pathol"},{"key":"9878_CR87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/gyno.1998.5046","volume":"70","author":"EJ Kaplan","year":"1998","unstructured":"Kaplan EJ, Caputo TA, Shen PUF, Sassoon RI, Soslow RA (1998) Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case. Gynecol Oncol 70:289\u2013294","journal-title":"Gynecol Oncol"},{"key":"9878_CR88","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","volume":"106","author":"TM Friebel","year":"2014","unstructured":"Friebel TM, Domchek SM, Rebbeck TR (2014) Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. J Natl Cancer Inst 106:dju091","journal-title":"J Natl Cancer Inst"},{"key":"9878_CR89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/OGX.0000000000000156","volume":"70","author":"C Garcia","year":"2015","unstructured":"Garcia C, Powell CB (2015) A comprehensive approach to the identification and management of the BRCA patient. Obstet Gynecol Surv 70:131\u2013143","journal-title":"Obstet Gynecol Surv"},{"key":"9878_CR90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/M13-1684","volume":"160","author":"HD Nelson","year":"2014","unstructured":"Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160:255\u2013266","journal-title":"Ann Intern Med"},{"key":"9878_CR91","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80\u201387","journal-title":"J Natl Cancer Inst"},{"key":"9878_CR92","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudi CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615","journal-title":"N Engl J Med"},{"key":"9878_CR93","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van\u2019t Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, the prevention and observation of surgical end points study group (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616\u20131622","journal-title":"N Engl J Med"},{"key":"9878_CR94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/IGC.0b013e3182849dba","volume":"23","author":"CK Anderson","year":"2013","unstructured":"Anderson CK, Wallace S, Guiahi M, Sheeder J, Bahbakht K, Spillman MA (2013) Risk-reducing salpingectomy as preventive strategy for pelvic serous cancer. Int J Gynecol Cancer 23:417\u2013421","journal-title":"Int J Gynecol Cancer"},{"key":"9878_CR95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fonc.2014.00021","volume":"4","author":"T Schenberg","year":"2014","unstructured":"Schenberg T, Mitchell G (2014) Prophylactic bilateral salpingectomy as a prevention strategy in women at high-risk of ovarian cancer: a mini-review. Front Oncol 4:21","journal-title":"Front Oncol"},{"key":"9878_CR96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","volume":"121","author":"JS Kwon","year":"2013","unstructured":"Kwon JS, Tinker A, Pansegrau G, McAlpine J, Housty M, McCullum M, Gilks CB (2013) Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121:14\u201324","journal-title":"Obstet Gynecol"},{"issue":"11","key":"9878_CR97","first-page":"CD002748","volume":"10","author":"L Lostumbo","year":"2010","unstructured":"Lostumbo L, Carbine NE, Wallace J (2010) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 10(11):CD002748","journal-title":"Cochrane Database Syst Rev"},{"key":"9878_CR98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/000313481307900233","volume":"79","author":"F Zagouri","year":"2013","unstructured":"Zagouri F, Chrysikos DT, Sergentanis TN, Giannakopoulou G, Zografos CG, Papadimitriou CA, Zografos GC (2013) Prophylactic mastectomy: an appraisal. Am Surg 79:205\u2013212","journal-title":"Am Surg"},{"key":"9878_CR99","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1245\/s10434-015-4532-1","volume":"22","author":"F Felice De","year":"2015","unstructured":"De Felice F, Marchetti C, Musella A, Palaia I, Perniola G, Musio D, Muzii L, Tombolini V, Panici PB (2015) Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol 22:2876\u20132880","journal-title":"Ann Surg Oncol"},{"key":"9878_CR100","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t\u2019veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlison G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967\u2013975","journal-title":"JAMA"},{"key":"9878_CR101","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10549-013-2765-x","volume":"142","author":"SL Ingram","year":"2013","unstructured":"Ingram SL, Sperrin M, Baildam A, Ross GL, Clayton R, Lalloo F, Buchan I, Howell A, Evans DGR (2013) Risk-reducing surgery increases survival in BRCA1\/2 mutation carriers unaffected at time of family referral. Breast Cancer Res Treat 142:611\u2013618","journal-title":"Breast Cancer Res Treat"},{"key":"9878_CR102","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","volume":"32","author":"APM Finch","year":"2014","unstructured":"Finch APM, Lubinski J, M\u00f8ller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadiraian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA (2014) Impact of oophorectomy on cancer incidence and mortality in women with BRCA1 or BRCA2 mutation. J Clin Oncol 32:1547\u20131553","journal-title":"J Clin Oncol"},{"key":"9878_CR103","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM199705153362022","volume":"336","author":"D Schrag","year":"1997","unstructured":"Schrag D, Kuntz KM, Garber JE, Weeks JC (1997) Decision analysis\u2014effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336:1465\u20131471","journal-title":"N Engl J Med"},{"key":"9878_CR104","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/jco.2002.08.035","volume":"20","author":"MS Roosmalen van","year":"2002","unstructured":"van Roosmalen MS, Verhoef LCG, Stalmeier PFM, Hoogerbrugge N, van Daal WAJ (2002) Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. J Clin Oncol 20:2092\u20132100","journal-title":"J Clin Oncol"},{"key":"9878_CR105","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","volume":"20","author":"VR Grann","year":"2002","unstructured":"Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI (2002) Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis. J Clin Oncol 20:2520\u20132529","journal-title":"J Clin Oncol"},{"key":"9878_CR106","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2004.06.090","volume":"22","author":"K Armstrong","year":"2004","unstructured":"Armstrong K, Schwartz JS, Randall T, Rubin SC, Weber B (2004) Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1\/2 mutations: a decision analysis. J Clin Oncol 22:1045\u20131054","journal-title":"J Clin Oncol"},{"key":"9878_CR107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","volume":"28","author":"AW Kurian","year":"2010","unstructured":"Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers. J Clin Oncol 28:222\u2013231","journal-title":"J Clin Oncol"},{"key":"9878_CR108","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1055-9965.EPI-12-0149","volume":"21","author":"BM Sigal","year":"2012","unstructured":"Sigal BM, Munoz DF, Kurian AW, Plevritis SK (2012) A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 21:1066\u20131077","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9878_CR109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","volume":"133","author":"LL Holman","year":"2014","unstructured":"Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH (2014) Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecol Oncol 133:283\u2013286","journal-title":"Gynecol Oncol"},{"key":"9878_CR110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","volume":"136","author":"M Arts-de Jong","year":"2015","unstructured":"Arts-de Jong M, Harmsen MG, Hoogerbrugge N, Massuger LF, Hermens RP, de Hullu JA (2015) Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives. Gynecol Oncol 136:305\u2013310","journal-title":"Gynecol Oncol"},{"key":"9878_CR111","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","volume":"15","author":"MG Harmsen","year":"2015","unstructured":"Harmsen MG, Arts-de Jong M, Hoogerbrugge N, Maas AHEM, Prins JB, Bulten J, Teerenstra S, Adang EMM, Piek JMJ, van Doorn HC, van Beurden M, Mourits MJE, Zweemer RP, Gaarenstroom KN, Slangen BFM, Vos MC, van Lonkhuijzen LRCW, Massuger LFAG, Hermens RPMG, de Hullu JA (2015) Early salpingectomy (TUbectectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study. BMC Cancer 15:593","journal-title":"BMC Cancer"},{"key":"9878_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gynor.2014.03.003","volume":"9","author":"SH Kim","year":"2014","unstructured":"Kim SH, Frey MK, Blank SV (2014) Occult tubal carcinoma found at risk reducing salpingectomy in a BRCA1 carrier. Gynecol Oncol Case Rep 9:1\u20132","journal-title":"Gynecol Oncol Case Rep"},{"key":"9878_CR113","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfijord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9878_CR114","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M-C King","year":"2003","unstructured":"King M-C, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","journal-title":"Science"},{"key":"9878_CR115","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","volume":"23","author":"TR Rebbeck","year":"2005","unstructured":"Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van\u2019t Veer L, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, Eisen A, Domchek S, Armstrong K, Weber BL, PROSE Study Group (2005) Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 23:7804\u20137810","journal-title":"J Clin Oncol"},{"key":"9878_CR116","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","volume":"100","author":"A Eisen","year":"2008","unstructured":"Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA, the Hereditary Breast Cancer Clinical Study Group (2008) Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 100:1361\u20131367","journal-title":"J Natl Cancer Inst"},{"key":"9878_CR117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10689-008-9208-6","volume":"8","author":"CA Gabriel","year":"2009","unstructured":"Gabriel CA, Tigges-Cardwell J, Stopfer J, Erlichman J, Nathanson K, Domchek SM (2009) Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy. Fam Cancer 8:23\u201328","journal-title":"Fam Cancer"},{"key":"9878_CR118","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","volume":"10","author":"WD Foulkes","year":"2004","unstructured":"Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, B\u00e9gin LR, Narod SA (2004) Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 10:2029\u20132034","journal-title":"Clin Cancer Res"},{"key":"9878_CR119","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr953","volume":"7","author":"H Eerola","year":"2005","unstructured":"Eerola H, Heikkil\u00e4 P, Tamminen A, Aittom\u00e4ki K, Blomqvist C, Nevanlinna H (2005) Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 7:R93\u2013R100","journal-title":"Breast Cancer Res"},{"key":"9878_CR120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10689-015-9798-8","volume":"14","author":"Y Segev","year":"2015","unstructured":"Segev Y, Rosen B, Lubinski J, Gronwald J, Lynch HT, Moller P, Kim-Sing C, Ghadirian P, Karlan B, Eng C, Gilchrist D, Neuhausen SL, Eisen A, Friedman E, Euhus D, Ping S, Narod SA, Hereditary Breast Cancer Study Group (2015) Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study. Fam Cancer 14:383\u2013391","journal-title":"Fam Cancer"},{"key":"9878_CR121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","volume":"104","author":"ME Beiner","year":"2007","unstructured":"Beiner ME, Finch A, Rosen B, Lubinski J, Moller P, Ghadirian P, Lynch HT, Friedman E, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group (2007) The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol Oncol 104:7\u201310","journal-title":"Gynecol Oncol"},{"key":"9878_CR122","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","volume":"130","author":"Y Segev","year":"2013","unstructured":"Segev Y, Iqbal J, Gronwald J, Lynch HT, Moller P, Ghadirian P, Rosen B, Tung N, Kim-Sing C, Foulkes WD, Neuhausen SL, Senter L, Singer CF, Karlan B, Ping S, Narod SA, Hereditary Breast Cancer Study Group (2013) The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective study. Gynecol Oncol 130:127\u2013131","journal-title":"Gynecol Oncol"},{"key":"9878_CR123","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(05)71562-2","volume":"357","author":"SA Narod","year":"2001","unstructured":"Narod SA, Pal T, Graham T, Mitchell M, Fyles A (2001) Tamoxifen and risk of endometrial cancer. Lancet 357:65\u201366","journal-title":"Lancet"},{"issue":"Suppl 1","key":"9878_CR124","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","volume":"95","author":"MA Quinn","year":"2006","unstructured":"Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz APM, Ngan HYS, Pecorelli S (2006) Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S43\u2013S103","journal-title":"Int J Gynaecol Obstet"},{"key":"9878_CR125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/GCO.0000000000000140","volume":"27","author":"M Wuttke","year":"2015","unstructured":"Wuttke M, Phillips K-A (2015) Clinical management of women at high risk of breast cancer. Curr Opin Obstet Gynecol 27:6\u201313","journal-title":"Curr Opin Obstet Gynecol"},{"key":"9878_CR126","first-page":"111","volume":"1","author":"MJ Casey","year":"1995","unstructured":"Casey MJ, Bewtra C, Garcia-Padial J, Lynch HT (1995) Laparoscopic examination and assisted bilateral salpingo-oophorectomy hysterectomy for prophylactic removal of the ovaries and uterus in women at genetic risk for ovarian cancer. J Gynecol Tech 1:111\u2013114","journal-title":"J Gynecol Tech"},{"key":"9878_CR127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/gyn.1998.14.15","volume":"14","author":"MJ Casey","year":"1998","unstructured":"Casey MJ, Garcia-Padial J, Hakert D, Watson P (1998) Changing trends in surgical approaches to hysterectomy: an analysis of laparoscopic assisted vaginal hysterectomy in clinical practice. J Gynecol Surg 14:15\u201324","journal-title":"J Gynecol Surg"},{"key":"9878_CR128","first-page":"543","volume":"8","author":"A Finch","year":"2012","unstructured":"Finch A, Evans G, Narod SA (2012) BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations. Womens Health 8:543\u2013555","journal-title":"Womens Health"},{"key":"9878_CR129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/GME.0000000000000126","volume":"21","author":"C Marchetti","year":"2014","unstructured":"Marchetti C, Iadarola R, Palaia I, di Donato V, Perniola G, Muzii L, Panici PB (2014) Hormone therapy in oophorectomized BRCA1\/2 mutation carriers. Menopause 21:763\u2013768","journal-title":"Menopause"},{"key":"9878_CR130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ygyno.2015.06.020","volume":"138","author":"C Garcia","year":"2015","unstructured":"Garcia C, Lyon L, Conell C, Littell RD, Powell CB (2015) Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy. Gynecol Oncol 138:723\u2013726","journal-title":"Gynecol Oncol"},{"key":"9878_CR131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/humupd\/6.3.244","volume":"6","author":"A Cano","year":"2000","unstructured":"Cano A, Hermenegildo C (2000) The endometrial effects of SERMs. Hum Reprod Update 6:244\u2013254","journal-title":"Hum Reprod Update"},{"key":"9878_CR132","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/OGX.0b013e31828baef9","volume":"68","author":"S Gizzo","year":"2013","unstructured":"Gizzo S, Saccardi C, Patrelli TS, Berretta R, Capobianco G, Di Gangi S, Vacilotto A, Bertocco A, Noventa M, Ancona E, D\u2019Antona D, Nardelli GB (2013) Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications. Obstet Gynecol Surv 68:467\u2013481","journal-title":"Obstet Gynecol Surv"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9878-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-016-9878-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9878-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T10:52:15Z","timestamp":1600167135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-016-9878-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,13]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9878"],"URL":"https:\/\/doi.org\/10.1007\/s10689-016-9878-4","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,13]]}}}